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Background
New technologies for mitral valve repair are emerging.
One of them is NeoChord DS1000 system (Neochord,
Inc., Minneapolis, MN). This device is designed to deliver
artificial chordae tendinae to mitral valve leaflets on a
beating heart through left ventricle wall. This is our initial
experience with this device.
Methods
This data is part of multi-center, nonrandomized, prospec-
tive Transapical Artificial Chordae Tendinae [TACT] trial.
13 patients with severe mitral regurgitation caused by
isolated posterior mitral valve leaflet prolapse, were
included in the study. The operation was done through
left anterolateral thoracotomy on a beating heart. With
TEE guidance, the NeoChord DS1000 was introduced into
the left ventricle. The prolapsing segment was grasped
with the device and ePTFE suture was attached to the pos-
terior leaflet. Six patients received 2 ePTFE sutures to
achieve competence of mitral valve, four patients - 3
ePTFE sutures, and two patients - 4 ePTFE sutures. At six
months follow up all patients had TTE.
Results
Median duration of operation was 110 min (80 to 150
min). Less than second degree mitral regurgitation in six
months was achieved in 11 (85%) patients. 1 (8%) patient
has developed recurrent third degree mitral regurgitation
in one month. 1 (8%) patient has been converted to con-
ventional mitral valve repair during procedure. There were
no other adverse events related to the procedure.
Conclusions
Treatment of mitral regurgitation by off-pump implanta-
tion of artificial chordae using NeoChord device is feasi-
ble and safe method in selected group of patients. To
evaluate long term results and improve patient selection
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